Drugs / BI 3810477
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06984926 | Jun 2025 → Mar 2026 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT06631430 | Oct 2024 → Jun 2025 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BI 3810477 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06984926 ↗ |